Cheetah Medical is the pioneer and global leading provider of 100% noninvasive hemodynamic monitoring technologies which are designed for use in critical care, operating room and emergency department settings for a wide variety of patient populations.
The company was founded in Israel in the early 2000’s with the mission of helping clinicians manage their patient’s fluid status. Currently headquartered in Boston, Massachusetts, Cheetah also has offices in Tel Aviv, Israel and Vancouver, Washington. Cheetah sells through a direct sales organization in the US while utilizing a network of distributors to reach 25+ countries outside the US.
About Cheetah Medical’s Technology
The CHEETAH NICOM and Starling SV systems use a proprietary algorithm to calculate hemodynamic parameters to assess heart function. Medical professionals use this information to assess patients’ unique volume requirements to maintain optimal fluid volume and perfuse critical organs. Cheetah Medical technologies are designed to enable more confident and informed treatment decisions that support the clinical goals of improving patient outcomes and driving economic efficiencies.
Cheetah has developed a robust portfolio of clinical data including several peer review studies that document the accuracy and clinical utility of the CHEETAH NICOM™ and Starling™ SV systems. With over 60 peer-reviewed publications from a global cadre of authors, Cheetah’s technology is incredibly well-documented.Download the Cheetah Medical Fact Sheet